Apotex Inc. recalls Dorzolamide HCI/Timolol Maleate Ophthalmic Solution 22.3mg/6.8mg per mL, 10mL bottle, For Topical Application in the Eye
Recalled August 8, 2012 · FDA recall D-1439-2012 · Apotex
Hazard
Presence of Particulate Matter: Lots identified in this recall notification may contain small particulates. · FDA Class II
Units
119,794 Bottles
Sold at
Nationwide and Puerto Rico
Description
Presence of Particulate Matter: Lots identified in this recall notification may contain small particulates.
Product
Dorzolamide HCI/Timolol Maleate Ophthalmic Solution 22.3mg/6.8mg per mL, 10mL bottle, For Topical Application in the Eye, Sterile Ophthalmic Solution, Rx Only, Mfg by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9
Manufacturer(s)
Apotex Inc.
Made in
Canada
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →